Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors

In this webinar, representatives from the Division of Cancer Control and Population Sciences (DCCPS) explained the goals and objectives for RFA-CA-19-033, Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required).

This Funding Opportunity Announcement (FOA) will support applications to develop and test interventions that prevent, mitigate, or manage adverse outcomes in pediatric and/or adolescent/young adult (AYA) cancer survivors and/or evaluate models of care that strengthen coordination, continuity, and care quality, or that reduce access barriers to needed services including follow-up care, and that improve outcomes across the survivor’s lifespan.

Note: RFA-CA-19-033 is associated with the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act of 2018, which is intended to maximize and accelerate discovery, development, and availability of promising childhood cancer treatments. It is also associated with the Beau Biden Cancer Moonshot℠ Initiative, which is intended to accelerate cancer research.